CSIMarket
 
Rallybio Corporation  (NASDAQ: RLYB)
 

Rallybio's Customers Performance

RLYB



 
RLYB's Source of Revenues

List of RLYB Customers




for the same period Rallybio Corporation

List of RLYB Customers





Rallybio's Comment on Sales, Marketing and Customers





  News about Rallybio Corporation Contracts

Milestone for Rare Disease Therapy Rallybio Receives $12.5 Million Boost for REV102 Development,

Rallybio Receives $12.5 Million Milestone Payment from Recursion for REV102 Advancements Rallybio Corporation, a clinical-stage biotechnology company listed on Nasdaq as RLYB, recently announced a significant development in its collaborative efforts with Recursion, a biotechnology firm renowned for its innovative approach to drug discovery and development. The announcement detailed an equity milestone payment of $12.5 million made to Rallybio by Recursion, marking a pivotal financial and developmental milestone for their investigational drug, REV102. Background on Rallybio and RecursionRallybio Corporation is recognized for its dedication to transforming scientific breakthroughs into viable medical therap...












RLYB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Rallybio Corporation 98.80 0.86 -7.82 14
SUBTOTAL 0.00 0.00 0.00 -

Sources: Rallybio Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Rallybio Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Rallybio Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.